-
ArticlePublication 2022Systematic Review of Patient Preferences, Expectations, and Values for Management and Treatment of Hypertension
This analysis summarized the evidence on the preferences, expectations, and values of hypertension management and …
This analysis summarized the evidence on the preferences, expectations, and values of hypertension management and treatment in hypertensive patients. The authors reviewed 24 studies involving 8,701 participants. Despite varying areas of focus, common themes included (1) patients often obtain hypertension information from their physicians and prefer shared patient-centered decision-making, and (2) side effects, cost, and convenience are important factors for patients when selecting a treatment regimen for hypertension.
Preferences/Values | Health Outcomes | Chronic Disease/Risk | Clinical Care -
ArticlePublication 2017Benefit and Harm of Intensive Blood Pressure Treatment: Derivation and Validation of Risk Models Using Data from the Sprint and Accord Trials
Intensive blood pressure (BP) treatment can avert cardiovascular disease (CVD) events but can cause some …
Intensive blood pressure (BP) treatment can avert cardiovascular disease (CVD) events but can cause some serious adverse events. The authors sought to create risk calculators to estimate individual patients’ chances of benefit and harm from intensive treatment. They developed statistical models of cardiovascular events and serious adverse events from individual participant data from the Systolic Blood Pressure Intervention Trial (SPRINT) of intensive blood pressure treatment (N = 9,069 with complete covariate data) and validated them…
Probability/Bayes | Health Outcomes | Evidence Synthesis | Chronic Disease/Risk -
ArticlePublication 2017Personalizing the Intensity of Blood Pressure Control, Modeling the Heterogeneity
The Systolic Blood Pressure Intervention Trial (SPRINT) suggests that, on average, hypertensive patients at high …
The Systolic Blood Pressure Intervention Trial (SPRINT) suggests that, on average, hypertensive patients at high cardiovascular risk would have less cardiovascular morbidity and mortality but higher treatment-related adverse events with an intensive blood pressure treatment strategy as compared with a standard blood pressure treatment strategy. Applying these population-level results to individual patients is challenging, as each patient may have different benefits and risks than the average patient in SPRINT. Using patient-level data from SPRINT, the authors developed…
Probability/Bayes | Health Outcomes | Evidence Synthesis | Chronic Disease/Risk | Health Systems | Health/Medicine | Science/Technology | North America
3 Shown
General Resources
Teaching Resources
Collections
Format
Learner Level
Teaching Topic